Study finds potential therapeutic targets to inhibit colorectal cancer progression

UK hits COVID vaccination ‘landmark’ in care homes
1 February 2021
New insights into B cells and why humans can produce trillions of disease-fighting antibodies
1 February 2021

Study finds potential therapeutic targets to inhibit colorectal cancer progression

Nagoya University researchers and colleagues have revealed that colorectal cancer tissues contain at least two types of fibroblasts (a type of cells found in connective tissue), namely, cancer-promoting fibroblasts and cancer-restraining fibroblasts, and that the balance between them is largely involved in the progression of colorectal cancer. Their findings, recently published in the journal Gastroenterology, suggest that artificially altering the balance between the two types of cells could curb the spread of colorectal cancer tumors, which may become an effective strategy for preventing cancer progression.

Comments are closed.